10x Genomics Inc. Class A Common Stock (0A88)
LSE
Closed
Oct 8, 2026
Day's Range
70.9052 wk Range
11.17Overview - 0A88 - 10x Genomics Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
10.44B
P/E (Trailing)
‪-19.38‬
Price / Book
‪13.22‬
EV / EBITDA
‪-253.51‬
Profitability
Gross Margin
‪3.16%‬
Profit Margin
‪-12.17%‬
Operating Margin
‪-15.19%‬
Return on Assets
‪-5.04%‬
Return on Equity
‪-9.39%‬
Ownership
Shares Outstanding
3.15M
Float
118.19M
Held by Insiders
‪1.46%‬
Held by Institutions
‪120.20%‬
Price stats
Beta
‪2.07‬
50-Day Avg
‪45.52‬
200-Day Avg
‪48.11‬
Peers - 0A88 - 10x Genomics Inc. Class A Common Stock
Peer Comparison
Compared with companies in Health Information Services listed on LSE.
- 0A88LSE10x Genomics Inc.+86.34%52-week change-19.39P/E (Trailing)‪-12.17%‬Profit Margin
- TEMLSETempleton Emerging Markets Fund+36.43%52-week change4.13P/E (Trailing)—Profit Margin
- DXRXLSEDiaceutics plc+11.96%52-week change105.00P/E (Trailing)‪0.25%‬Profit Margin
- KOOLSEKooth plc+23.43%52-week change12.23P/E (Trailing)‪9.42%‬Profit Margin
- 0MSDLSECompuGroup Medical SE & Co. KGaA+11.38%52-week change9.54P/E (Trailing)‪7.12%‬Profit Margin
- 0QONLSEAscom Holding AG+39.21%52-week change0.16P/E (Trailing)‪6.26%‬Profit Margin
- AIAILSEL&G Artificial Intelligence UCITS ETF+34.78%52-week change0.37P/E (Trailing)—Profit Margin
Profile Summary - 0A88 - 10x Genomics Inc. Class A Common Stock
About
10x Genomics Inc. is a life science technology company that provides advanced tools for high-resolution analysis of biological systems. The company focuses on single-cell and spatial biology, offering integrated solutions that combine instruments, consumables, and software for researchers worldwide. Its core product…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
